Information was received from a consumer regarding a patient who was receiving morphine, baclofen, and one unknown drug (unknown con centration and dose) via an implantable pump.Indication for use was non-malignant pain.The date of the event was unknown.It was reported the pump battery failed.The healthcare provider had been increasing the drug.The pump did not last the full amount of time for normal battery depletion.No further complications were reported.
|
Additional information was received via saol.It was reported the patient is caucasian and was(b)(6) at the time of the event onset.On (b)(6)2015, the patient started treatment with compounded baclofen 425 ¿g/ml at an unknown dose.Concomitant products included alpha-lipoic acid, vitamin b12, biotin, vitamin c, coq-10, vitamin b2, vitamin d3, cytomel (liothyronine sodium), flonase (fluticasonepropionate), levoxyl (levothyroxine sodium), magnesium, maxalt (rizatriptan benzoate), milk thistle, nifedipine, nystatin/triamcinolone,ondansetron, pataday (olopatadine hydrochloride), promethazine, promethegan (promethazine), relistor (methylnaltrexone bromide),senokot, skelaxin (metaxalone), trazadone, vivelle-dot (estradiol), voltaren (diclofenac sodium), "vsl #3," wellbutrin (bupropionhydrochloride) and zenpep (pancrelipase).Medical history included non-malignant pain, chronic pain (20 years), nerve pain following laminectomy (2011).On an unreported date, she started treatment with hydromorphone 1000 ¿g/ml at 132.3 ¿g/day.
|